| Charles Clark Iii, MD | |
|
9850 W St Lukes Dr, Nampa, ID 83687-7912 | |
| (208) 706-2663 | |
| (208) 489-4300 |
| Full Name | Charles Clark Iii |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 10 Years |
| Location | 9850 W St Lukes Dr, Nampa, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114346434 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | M-15579 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| First Choice Home Care | Boise, ID | Home health agency |
| St Luke's Nampa Medical Center | Nampa, ID | Hospital |
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this testing service. This is an ELISA-based assay which simply requires a small blood sample from the patient in order to quantify the amount of the tumor marker in their serum.
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, particularly in China. However, HCC remains one of the more difficult cancers to treat. It is important to screen for new anti-cancer drugs. A number of dietary compounds possess anti-cancer properties. These dietary compounds may modify the activity of specific targets that control cell proliferation and apoptosis. Galangin could inhibit the methoxyresorufin O-demethylase activity of CYP1A2, CYP1A1 and P-form phenolsulfotransferase.
Researchers have identified four genes newly associated with severe childhood obesity. They also found an increased burden of rare structural variations in severely obese children.
The number of young people who had a food or digestive allergy increased 18 percent between 1997 and 2007, according to a new report by the Centers for Disease Control and Prevention. In 2007, approximately 3 million U.S. children and teenagers under age 18 - or nearly 4 percent of that age group - were reported to have a food or digestive allergy in the previous 12 months, compared to just over 2.3 million (3.3 percent) in 1997.
› Verified 7 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this testing service. This is an ELISA-based assay which simply requires a small blood sample from the patient in order to quantify the amount of the tumor marker in their serum.
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, particularly in China. However, HCC remains one of the more difficult cancers to treat. It is important to screen for new anti-cancer drugs. A number of dietary compounds possess anti-cancer properties. These dietary compounds may modify the activity of specific targets that control cell proliferation and apoptosis. Galangin could inhibit the methoxyresorufin O-demethylase activity of CYP1A2, CYP1A1 and P-form phenolsulfotransferase.
Researchers have identified four genes newly associated with severe childhood obesity. They also found an increased burden of rare structural variations in severely obese children.
The number of young people who had a food or digestive allergy increased 18 percent between 1997 and 2007, according to a new report by the Centers for Disease Control and Prevention. In 2007, approximately 3 million U.S. children and teenagers under age 18 - or nearly 4 percent of that age group - were reported to have a food or digestive allergy in the previous 12 months, compared to just over 2.3 million (3.3 percent) in 1997.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Clark Iii, MD 2718 W Jetton Ave, Tampa, FL 33629-5327 Ph: (813) 784-0002 | Charles Clark Iii, MD 9850 W St Lukes Dr, Nampa, ID 83687-7912 Ph: (208) 706-2663 |
News Archive
GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this testing service. This is an ELISA-based assay which simply requires a small blood sample from the patient in order to quantify the amount of the tumor marker in their serum.
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, particularly in China. However, HCC remains one of the more difficult cancers to treat. It is important to screen for new anti-cancer drugs. A number of dietary compounds possess anti-cancer properties. These dietary compounds may modify the activity of specific targets that control cell proliferation and apoptosis. Galangin could inhibit the methoxyresorufin O-demethylase activity of CYP1A2, CYP1A1 and P-form phenolsulfotransferase.
Researchers have identified four genes newly associated with severe childhood obesity. They also found an increased burden of rare structural variations in severely obese children.
The number of young people who had a food or digestive allergy increased 18 percent between 1997 and 2007, according to a new report by the Centers for Disease Control and Prevention. In 2007, approximately 3 million U.S. children and teenagers under age 18 - or nearly 4 percent of that age group - were reported to have a food or digestive allergy in the previous 12 months, compared to just over 2.3 million (3.3 percent) in 1997.
› Verified 7 days ago
Dr. Jonathon Curtis Wolf, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9850 W St Lukes Dr Ste 215, Nampa, ID 83687 Phone: 208-706-2663 Fax: 208-489-4300 | |
Shane A Andrew, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4424 E Flamingo Ave, Suite 110, Nampa, ID 83687 Phone: 208-288-4700 Fax: 208-288-4720 | |
Keith G Holley, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4424 E Flamingo Ave, Suite 110, Nampa, ID 83687 Phone: 208-288-4700 Fax: 208-288-4720 | |
Tildon C Robinson Iv, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4424 E Flamingo Ave, Suite 110, Nampa, ID 83687 Phone: 208-288-4700 Fax: 208-288-4720 | |
Aaron Franklin Newton, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4400 E Flamingo Ave Ste 200, Nampa, ID 83687 Phone: 208-302-2700 Fax: 208-302-2725 | |
Jared T Armstrong, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9850 St Lukes Dr, Nampa, ID 83687 Phone: 208-706-2663 |